Dysregulation of COL1A1 expression leads to ECM stiffness, impaired adipogenesis, and disrupted lipid metabolism, contributing to metabolic diseases such as obesity and insulin resistance [52]. This evidence concerns the gene COL1A1 and Other metabolic disease.